prognosis of ampullary cancer based on immunohistochemical type and expression of osteopontin壶腹癌的预后基于免疫组织化学类型和骨桥蛋白的表达.pdfVIP

prognosis of ampullary cancer based on immunohistochemical type and expression of osteopontin壶腹癌的预后基于免疫组织化学类型和骨桥蛋白的表达.pdf

  1. 1、本文档共7页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
prognosis of ampullary cancer based on immunohistochemical type and expression of osteopontin壶腹癌的预后基于免疫组织化学类型和骨桥蛋白的表达

Zhao et al. Diagnostic Pathology 2011, 6:98 /content/6/1/98 RESEARCH Open Access Prognosis of ampullary cancer based on immunohistochemical type and expression of osteopontin * Xiang-qian Zhao, Jia-hong Dong , Wen-zhi Zhang and Zhe Liu Abstract Background: Ampullary cancer (AC) was classified as pancreatobiliary, intestinal, or other subtype based on the expression of cytokeratin 7 (CK7) and cytokeratin 20 (CK20). We aimed to explore the association of AC subtype with patient prognosis. Methods: The relationship of AC subtype and expression of Osteopontin (OPN) with the prognosis of 120 AC patients after pancreaticoduodenectomy was investigated. Results: The patients had pancreatobiliary (CK7+ - - + /CK20 , n = 24, 20%), intestinal (CK7 /CK20 , n = 29, 24.2%) or + + - - other (CK7 /CK20 or CK7 /CK20 , n = 67, 55.8%) subtypes of AC, and their median survival times were 23 ± 4.2, 38 ± 2.8 and 64 ± 16.8 months, respectively. The survival times of 64 OPN- patients (53.3%) and 56 OPN+ patients (46.7%) were 69 ± 18.4 and 36 ± 1.3 months, respectively. There was no significant effect of AC subtype on survival of OPN- patients. For OPN+ patients, those with pancreatobiliary AC had a shorter survival time (22 ± 6.6 months) than those with intestinal AC (37 ± 1.4 months, p = 0.041), and other AC subtype (36 ± 0.9 months, p = 0.010); intestinal and other AC subtypes had similar survival times. Conclusions: The prognosis of AC patients can be estimated based on immunohistochemical classification and OPN status. Keywords: ampullary cancer, osteopontin, survival analysis, immunohistochemistry, classific

您可能关注的文档

文档评论(0)

xyz118 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档